Literature DB >> 2110467

Osteopenia in pregnancy during long-term heparin treatment: a radiological study post partum.

T Dahlman1, N Lindvall, M Hellgren.   

Abstract

Osteopenia, sometimes with compression fractures of the spine, is a side-effect of long-term heparin treatment. The frequency is unknown. In this study, 70 women were given subcutaneous heparin as therapy for, or prophylaxis against, thromboembolism during pregnancy. All, except two, were examined by X-ray of the spine and hip first week post partum. The duration of treatment and the dosage of heparin varied. There were 12 (17%) with obvious osteopenia, including two women with multiple fractures of the spine (3%). Re-examination 6-12 months post partum showed that the changes were reversible in most cases. Another 18 women were examined about three years after heparin treatment during pregnancy. No obvious osteopenia was found among them or in a control group of 30 women examined in the first week post partum. The degree of osteopenia was not correlated with either the heparin dose or the duration of treatment. Women treated with heparin in consecutive pregnancies do not seem to have an increased risk of osteopenia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110467     DOI: 10.1111/j.1471-0528.1990.tb01785.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  10 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.

Authors:  Mark H Eckman; Pablo Alonso-Coello; Gordon H Guyatt; Shanil Ebrahim; Kari A O Tikkinen; Luciane Cruz Lopes; Ignacio Neumann; Sarah D McDonald; Yuqing Zhang; Qi Zhou; Elie A Akl; Ann Flem Jacobsen; Amparo Santamaría; Joyce Maria Annichino-Bizzacchi; Wael Bitar; Per Morten Sandset; Shannon M Bates
Journal:  Thromb Res       Date:  2015-05-22       Impact factor: 3.944

Review 3.  Challenges of Anticoagulation Therapy in Pregnancy.

Authors:  Annemarie E Fogerty
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

4.  The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.

Authors:  B T Colvin; T W Barrowcliffe
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

Review 5.  Emerging concepts in the diagnosis and management of venous thromboembolism during pregnancy.

Authors:  M M Burns
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

Review 6.  Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations.

Authors:  M T Nurmohamed; H ten Cate; J W ten Cate
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 7.  Management of Venous Thromboembolism in Pregnancy.

Authors:  Annemarie E Fogerty
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-07-23

8.  Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. Maternal and Neonatal haemostasis Working Party of the Haemostasis and Thrombosis Task.

Authors: 
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

Review 9.  Drug-induced disorders of bone metabolism. Incidence, management and avoidance.

Authors:  G Jones; P N Sambrook
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

10.  Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.

Authors:  O Blétry; A M Piette
Journal:  Infect Dis Obstet Gynecol       Date:  1997
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.